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Introduction 
Osteoarthritis is one of the most common diseases which 
has affected many people; this disease increases with 
age. In general, it may be said that approximately 14% of 
adults in United States and 40% of the population under 
65 years old in Britain and Australia suffer from this 
disease; this disease prevalence is growing.1 Osteoarthritis 
is an example of physical and motor disability and one 
of the most important causes of functional disabilities in 
individuals, and imposes significant costs to individuals 
and consequently, to society.2 Knee osteoarthritis 
(KOA) is one of the most common osteoarthritis types 
and is associated with symptoms such as knee stiffness, 
pain, and limited movement range of knee joint. These 
conditions lead to physical function impairment, limited 
independence in doing daily life activities, decreased 
quality of life, and other disabilities.3,4
KOA is also known as arthritis or knee joint stiffness; 
it mainly affects the articular cartilage. The articular 
cartilage is a soft tissue which is inside the joint and 
between bones; in the case of its damage, the bones will 
rub on each other and extended bone will be created 
around the joint. Ultimately, the ligaments and muscles 
around the joint will be narrowed and weakened.1-4 There 
are several different treatments to control this disease 
(pharmacotherapy, surgery, physiotherapy, exercise 
therapy). It seems that the use of these methods depends 
on disease stage and patient’s specific condition. In general, 
however, the logic and philosophy of these methods is 
relieving patient from pain, make him/her independent 
in doing daily life activities, and improving his/her life.5 
Due to numerous complications which are associated 
with using non-steroidal drugs, using them to control 
this disease is limited.5 Recently, other therapies which 
are based on rehabilitation methods (such as exercise 
therapy, tensile muscle movement, electrical stimulation, 
acupuncture, and heat therapy) are more considered by 
physicians than using non-steroidal drugs.6 Low-level 
laser therapy (LLLT) is one of the safe and non-invasive 
methods which has recently attracted the attention of 
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Introduction: Low-level laser therapy (LLLT) was introduced as an alternative non-invasive 
treatment for osteoarthritis, but its effectiveness is still controversial. The main objective of this 
article was to determine the safety and efficacy of LLLT in patients with knee osteoarthritis (KOA).
Methods: In order to gather evidence, main medical databases as well as relevant websites were 
browsed without time limit. We searched with appropriate keywords and strategies. After quality 
assessment of studies, study data were extracted by two reviewers. Standard mean difference 
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pain at activity (P = 0.01), total pain (P = 0.03), WOMAC function (P = 0.01), WOMAC stiffness 
(P = 0.02) and WOMAC total (P < 0.0001) in favor of the LLLT. There was no significant difference 
between LLLT and Placebo in WOMAC pain (P = 0.09) and range of motion (P = 0.1). 
Conclusion: In spite of some positive findings, this meta-analysis lacked data on how LLLT 
effectiveness is affected with important factors: wavelength, energy density, treatment duration, 
numbers of sessions the treatment, severity of KOA and site of application.
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many researchers and specialists for treatment of KOA.7
Low-power laser therapy is a therapeutic approach 
which uses low intensity light-emitting in range of 540-
830 nm light. It seems that the therapeutic effects of this 
procedure emerge by photochemical reactions which 
change permeability of cell membrane, increase build-
up of mRNA, and lead to cell proliferation. The causes of 
these effects are not heat; like in surgery laser. The LLLT 
is used in many different diseases and mainly in pain 
control. Simply, it may be said that there are two types 
of lasers: low power and high power. The high-power 
lasers cut the tissue and release heat. However, the low-
power lasers do not release heat and do not damage the 
tissue; they have the potential to produce photochemical 
reactions and improve the metabolism of cells. They are 
named low power lasers because they have a density of 
less than 5.0 W/cm2; they are also referred to as cold lasers 
or soft lasers. These lasers react in tissue and without 
causing heat, stimulate or inhibit the cells.8
After radiation of laser photons into cells, the cellular 
response begins with the activation of photoacceptors 
which are in the respiratory chain in mitochondria. 
Then, the cell redox and cell membrane state change, 
calcium displaces, pH changes, CAMP is activated, and 
DNA is dubbed; all of these lead to protein synthesis. In 
this way, the cellular responses extend from cell surface 
to tissue and organ surfaces and cause effects such as 
anti-inflammation, anti-edema and swelling, analgesia, 
cell proliferation, neovascularization and accelerated 
recovery, shifting metabolism to aerobic, and balancing 
immune system. In general, the physiological responses of 
tissue to low-power lasers include biological stimulation 
of system, effects on immune system, anti-inflammatory 
and anti-edema effects, effects on vessels and circulation, 
effects on lymph, effect on wound healing, analgesic 
effect, and effects on nerves.8 However, it seems that 
there are some uncertainties regarding the use of this 
therapeutic approach in people with KOA and the results 
of some studies are contradictory.9
Despite the broad clinical application of LLLT and also due 
to numerous randomized controlled trial (RCT) papers in 
terms of safety and efficacy of low power laser in people 
with KOA, the results of these articles are sometimes in 
contradiction with each other and its effectiveness is still 
in doubt. On the other hand, there are few systematic and 
meta-analyses studies that clarify the efficacy and safety 
of LLLT in these patients. The last systematic study that 
has been conducted in this area in recent years belongs 
to Huang et al.10 However, the study does not encompass 
some related articles, does not consider follow-up 
period of outcomes in the analysis and does not analyze 
consequences such as pain at rest, pain during activities 
and quality of life. Accordingly, we aimed to alleviate 
some of these limitations, to have a more comprehensive 
analysis of the safety and effectiveness of low power laser 
in people with KOA and ultimately contribute to an 
evidence-based decision making and policy on the use of 
this technology in this group of patients.
Methods 
This study conforms to all PRISMA guidelines and reports 
the required information accordingly. We performed 
a systematic review of best evidence using Cochrane 
guidelines. Our structured question for this review was as 
follows in Box 1.
Search for Evidence and Article Selection
We searched the most important and appropriate 
electronic medical databases including MEDLINE, 
PubMed, Cochrane library, Science Direct, Trip, Google 
Scholar, Thomson Reuters (formerly ISI) Web of 
Knowledge, SCOPUS and EMBASE as well as relevant 
websites were browsed without time constraint up to 
September 2016. The Me SH system was used, as well as 
‘AND’ and ‘OR’ between words of the same meaning and 
concept i.e. Low Level, Low Power, Laser Therapy, LLLT, 
LPLL, osteoarthritis and knee. The collected papers were 
organized in Endnote software. After deleting duplicate 
articles, 2 reviewers independently assessed the titles and 
abstracts of the search results and selected potentially 
relevant studies according to our main question (Box 
1). The articles that were deemed to be irrelevant to the 
research objectives were excluded. After collecting the full 
texts of articles which were related to the objectives of this 
study, the references of these articles were reviewed. The 
related references were identified and their full texts were 
reviewed. All stages of obtaining evidence and selecting 
studies were independently conducted by 2 authors. The 
disputes between them were resolved by discussion and 
by third party, if needed.
Inclusion and Exclusion Criteria
The inclusion criteria included (1) clinical trials articles, 
(2) people with KOA who were identified and approved 
by American College of Rheumatology indices, (3) the 
articles which compared low-power and LLLT with 
placebo laser, (4) articles which examined consequences 
such as pain, stiffness, performance, activity, and quality 
of life, and (5) articles which were published in English or 
Persian. The exclusion criteria included (1) fundamental 
research or studies on animals, (2) review articles, (3) 
articles which had not related statistical and clinical data, 
(4) articles which used LLLT or placebo laser along with 
another intervention, (5) duplicate articles which had 
up-to-date versions. Since the full text of all articles was 
available and we managed to get all of full articles, none of 
• Population: People with KOA;
• Intervention: Low-level(power) laser therapy;
• Comparator: Placebo Laser Therapy;
• Outcome: Pain relief, activity, range of motion, adverse 
side effects;
• Type of studies: RCTs and observational studies
Box 1. Components of Structured Question
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them was excluded.
Quality Assessment
The Cochrane’s Paper Quality Assessment Checklist was 
used to evaluate the quality of articles; this process was 
carried out independently by 2 authors and the disputes 
between them were resolved by discussion and by third 
party, if needed. Since this tool evaluates 7 aspects of 
bias risk, therefore, a 10-point scale was considered for 
article quality: scores above 7 indicate high quality, 
scores between 5 and 7 indicate medium quality of paper, 
and scores less than 5 indicate low quality of article. In 
dimensions 1 to 6, in general, the articles with low bias 
risk scored 1.5, the obscure bias risk scored 0.75, and the 
articles with high bias risk scored 0. In seventh dimension, 
the low bias risk scored 1, the obscure bias risk scored 0.5, 
and the high bias risk scored 0.
Data Collection
A special form was created in Excel 2013 to extract data 
from final articles. The needed data including general 
information (including title of article, year of publication, 
country, corresponding author) and specific information 
(including population size, sample size, type of study, 
statistical data related to each outcome, outcome follow-
up time, and other useful information) were collected 
by 2 authors independently. After completing the forms, 
the disputes between them were resolved by discussion 
and by third party, if needed. In cases where the article 
information was incomplete and specific information 
about article was needed, the corresponding author 
was called and in the case of cooperation, necessary 
information was taken.
Statistical Methods
Since the data of studied outcomes were continuous, 
the mean difference or standardized mean difference 
and reverse variance method were used to pollute these 
data. The Fix model was the statistical model which was 
used in the first step. However, in cases where there was 
high heterogeneity between studies, a randomized model 
was used. The chi-square and I² statistics were used for 
evaluating heterogeneity. The I2 more than or equal 
to 40% indicated high heterogeneity and less than this 
value indicated negligible heterogeneity.12 In all tests, the 
significant level was considered to be 0.05 (95% CI). The 
meta-analysis was performed using RevMan software, 
version 3.1.
Results 
Study Selection and Characteristics of Included Studies
As shown in Figure 1, in total, of 823 found papers, 
171 duplicate articles were identified and deleted. Of 
623 remaining articles, 519 papers were excluded based 
on studying titles and abstracts and 119 articles were 
excluded after studying the full text of articles. Finally, 
14 clinical trial articles entered into the stage of quality 
assessment and data extraction.
The total number of patient in LLLT group and placebo 
laser group were 350 and 328 respectively. The mean age 
of patients was between 40 to 90 years and follow-up time 
after treatment varied between 2 weeks to 1 year. All the 
including 14 studies were published between 1992 and 
2016. The characteristics of the included studies are listed 
in Table 1.
Study Quality
Quality assessment of the articles showed that out of 
14 articles, 9 had an acceptable quality, 2 had moderate 
quality and 3 had low quality (Figure 2).
1-Pain Relief
In this study, the result of pain relief was evaluated using 
VAS scale which is known as a tool for measuring the 
effectiveness of treatment. This scale is like a 10 cm ruler; 
one side of it indicates relief from pain and effectiveness 
of treatment and as we go to the other side of ruler, it 
indicates the presence of pain and at the end of which 
indicates that there is an intolerable pain. The scoring on 
this scale is done by patient him/herself. The patient him/
herself determines the amount of pain and scores it on 
ruler.27
1-1-Pain at Rest
Five studies14,16,17,19,24 including 579 patients (298 LLLT 
and 281  placebo) assessed the pain at rest outcomes of 
the patients. The overall inverse variance pooled SMD 
calculated for pain at rest was -0.45 (95% CI; -0.84, 
-0.07) in favor of the LLLT (P = 0.02, Figure 3). Test for 
heterogeneity was statistically significant (I²= 80%, 
P < 0.00001).
Figure 1. Search Results and Article Selection.
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Table 1. Characteristics of the Articles Included
Study Year Country
Mean Age (SD) No. of Patients
Follow up Reference
LLLT Placebo LLLT Placebo Total
Alfredo et al 2012 Brazil 61.15 (7.52) 62.25 (6.87) 24 22 46 3 & 11 Weeks 13
Alghadir et al 2014 Saudi Arabia 55.2 (8.14) 57 (7.77) 20 20 40 4 Weeks 14
Al Rashoud et al 2014 UK 52 (9) 56 (11) 26 23 49 6 & 24 Weeks 15
Fukuda et al 2011 Brazil 63.0 (9.0) 63.0 (8.0) 25 22 47 3 Weeks 16
Gur et al 2003 Turkey 58.64 (5.92) 60.52 (6.91) 30 30 60 4, 8, & 12 Weeks 17
Hegedus et al 2009 Hungary 49.48 49.48 18 9 27 2 & 8 Weeks 18
Hinman et al 2014 Australia 63.4 (8.7) 63.8 (7.5) 71 70 141 12 Weeks & 1 year 19
Kheshie et al 2014 Saudi Arabia 56.56 (7.86) 55.6 (11.02) 20 20 40 6 Weeks 20
Rayegani et al 2012 Iran 61.7 (2.9) 61.2 (7.2) 12 13 25 4 & 12 Weeks 21
Shen et al 2009 China 60.1 (6.83) 56.4 (7.41) 20 20 40 2 & 4 Weeks 22
Stelian et al 1992 Israel 68 2 (8.7) 68 2 (8.7) 18 17 35 8 Weeks 23
Tascioglu et al 2004 Turkey 62.86 (7.32) 64.27 (10.55) 20 20 40 3 & 24 Weeks 24
Youssef et al 2016 Saudi Arabia 67.5 (2.5) 66.3 (3.2) 18 15 33 8 Weeks 25
Yurtkuran 2007 Turkey 51.83 (6.83) 53.478 (7.13) 28 27 55 2 & 12 Weeks 26
Figure 2. Risk of Bias Summary of Articles Included. (+ low risk bias, - high risk bias, ? unclear risk)
1-2-Pain in Activity
Six studies14,16,17,19,24,26 including 689 patients (354 LLLT 
and 335 placebo) assessed the pain in activity outcomes 
of the patients. The overall inverse variance pooled SMD 
calculated for pain in activity was -0.31 (95% CI; -0.55, 
-0.07) in favor of the LLLT (P = 0.01, Figure 4). Test for 
heterogeneity was statistically significant (I² = 58%, 
P = 0.008).
1-3-Pain Total
Five studies13,15,19,20,23 including 478 patients (251 LLLT 
and 227  placebo) assessed the pain total outcomes of 
the patients. The overall inverse variance pooled SMD 
calculated for pain total was -0.41 (95% CI; -0.77, 
-0.04) in favor of the LLLT (P = 0.03, Figure 5). Test for 
heterogeneity was statistically significant (I² = 72%, 
P = 0.0007).
2- Knee Function
In this study, the effectiveness of treatment in relation 
to knee function was evaluated based on WOMAC 
measurement tool. This questionnaire is known as a 
standard for assessing and monitoring KOA. It is based 
on Likert scale of 0 to 4 (0 = no pain, 1 = mild pain, 
2 = moderate pain, 3 = severe pain, and 4 = intolerable or 
very severe pain) and is completed by patient him/herself. 
This questionnaire has 24 general questions which are 
divided into 3 subscales: 5 questions are related to pain, 2 
questions are related to stiffness, and 17 questions which 
constitute main body of this questionnaire are related to 
function. The minimum score in this questionnaire is 0 
and the maximum score is 96. The maximum score in 
pain, stiffness, and function subscales is 20, 8, and 68. 
In general, in this questionnaire, if the overall score or 
score in subscales will be closer to 0, it will indicate the 
effectiveness of treatment. If the scores will be higher, it 
will indicate adverse knee conditions.28
2-1-WOMAC Function
Seven studies13,14,19,20,22,24,26 including 637 patients (334 
LLLT and 303  placebo) assessed the WOMAC function 
outcomes of the patients. The overall inverse variance 
pooled SMD calculated for WOMAC function was -0.36 
(95% CI; -0.64, -0.08) in favor of the LLLT (P = 0.01, Figure 
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6). Test for heterogeneity was statistically significant (I² = 
65%, P = 0.0009).
2-2-WOMAC Pain
Seven studies13,14,19,20,22,24,26 including 637 patients (334 
LLLT and 303  placebo) assessed the WOMAC pain 
outcomes of the patients. The overall inverse variance 
pooled SMD calculated for WOMAC pain was -0.2 (95% 
CI; -0.42, 0.03). This difference was not statistically 
significant (P = 0.09, Figure 7). Test for heterogeneity was 
statistically significant (I²= 47%, P = 0.04).
2-3-WOMAC Stiffness
Six studies13,27 including 405 patients (211 LLLT and 194 
placebo) assessed the WOMAC stiffness outcomes of 
the patients. The overall inverse variance pooled SMD 
calculated for WOMAC stiffness was -0.23 (95% CI; 
-0.43, -0.03) in favor of the LLLT (P = 0.02, Figure 8). Test 
for heterogeneity was not statistically significant (I²= 0%, 
P = 0.65).
2-4-WOMAC Total
Seven studies13,14,17,19,22,24,26 including 585 patients (301 
LLLT and 284  placebo) assessed the WOMAC total 
Figure 3. Forest Plot Analysis of the Pain at Rest. Figure 5. Forest Plot Analysis of the Pain Total.
Figure 4. Forest Plot Analysis of the Pain in Activity. Figure 6. Forest Plot Analysis of the WOMAC Function.
Figure 7. Forest Plot Analysis of the WOMAC Pain.
outcomes of the patients. The overall inverse variance 
pooled SMD calculated for WOMAC total was -0.5 (95% 
CI; -0.73, -0.28) in favor of the LLLT (P < 0.0001, Figure 
9). Test for heterogeneity was statistically significant (I²= 
45%, P = 0.04).
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3- Range of Motion 
The recommended method of Marques was used to assess 
the effectiveness of knee range of motion (ROM).29
Four studies13,16,17,25 including 304 patients (137 LLLT and 
167  placebo) assessed the range of motion outcomes of 
the patients. The overall inverse variance pooled SMD 
calculated for range of motion was 0.63 (95% CI; -0.13, 
1.4). This difference was not statistically significant (P 
=0.1, Figure 10). Test for heterogeneity was statistically 
significant (I²= 91%, P < 0.00001).
4- Side Effects
Clinical trials which were analyzed in our study did not 
report any certain side effects of LLLT in patients.
Discussion
According to the World Health Organization’s Functioning, 
Disability, and Health Classification model (ICF), the 
disability is the result of action-reaction between health 
conditions, environmental factors, and personal factors. 
According to this model, the disability results from damage 
in anatomical structure and physiological function of 
body, and limitations in activity and participation. The 
Figure 8. Forest Plot Analysis of the WOMAC Stiffness.
Figure 9. Forest Plot Analysis of the WOMAC Total.
Figure 10. Forest Plot Analysis of the Range of Motion.
environmental and personal factors may play deterrent or 
facilitator role to affect the disabilities. KOA damages the 
structure and the physiological function of the knee joint. 
This damage may result in pain, functioning difficulties 
in daily living activities, and limited participation in living 
levels. On the other hand, environmental and personal 
barriers may increase the disability. LLLT has been 
introduced as a non-invasive therapeutic intervention for 
skeletal muscle disorders especially joint osteoarthritis 
during the past two decades. In spite of the widespread 
use of LLLT in KOA patients and also multiple trials in 
this area, there are inconsistent results regarding this 
technology efficacy. Stelian and colleagues’23 research in 
1992 was the first trial of laser effectiveness compared 
to placebo laser in KOA patients. The results of this trial 
showed improved function and pain reduction outcomes 
in patients who received laser treatment. After this trial, 
the studies conducted in the following years including 
Bulow et al30 and Tascioglu et al24 did not confirm the 
efficacy of LLLT compared to placebo laser. There were 
no significant differences between 2 groups in terms of 
performance improvement, pain relief and other clinical 
outcomes in these two studies.24,30 The efficacy of LLLT in 
KOA patients remains unknown due to these conflicting 
results. In spite of numerous clinical trials on LLLT 
efficacy in patients with KOA, there are few systematic 
and meta-analysis studies that clarify the LLLT efficacy 
and safety. This systematic and meta-analysis study was 
conducted based on the Cochrane Institute’s guide. After 
reviewing titles, abstracts and full texts of 823 articles, 
14 randomized clinical trials were randomly selected 
for analysis, of which, 9, 2 and 3 were of high, moderate, 
and low levels of quality, respectively. Total patients 
of LLLT group were 350 and total patients of placebo 
group were 328. All outcomes that were analyzed were 
continuous. Therefore, data were pooled using random 
effect model and statistical inverse variance method and 
the standardized mean difference, which was statistically 
significant at the 5% level. The results of the meta-
analysis on pain at rest, pain during activity, general 
pain, WOMAC function, WOMAC stiffness and overall 
WOMAC outcomes showed significant differences in 
favor of LLLT, but there were no statistically differences 
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between the 2 groups in WOMAC knee pain and range of 
motion outcomes. There is insufficient evidence to draw 
any firm conclusions regarding the use of laser for the 
treatment of KOA. However, no side effects were reported 
and no evidence of harm was found.
Results of Huang and colleagues’10 meta-analysis did 
not show significant differences between two groups in 
overall pain outcomes, but our meta-analysis suggests 
a significant pain reduction in patients who received 
LLLT. Huang meta-analysis also showed no significant 
differences between two groups in WOMAC stiffness 
and WOMAC functional outcomes, while our meta-
analysis indicated a significant improvement in patients 
who received LLLT. The results of our meta-analysis 
were similar to Huang and colleagues’ study10 concerning 
WOMAC pain and range of knee motion outcomes in 
which there were no significant differences between two 
groups.
Since there was a significant heterogeneity in results of 
outcome meta-analysis, it cannot be said with certainty 
that the LLLT impacts in reducing pain and improving 
function in patients with KOA.
The use of different wavelengths, treatment times, 
number of sessions, and adjuvant therapy such as 
physical therapy along with LLLT, attrition during follow-
up periods, illness severity, energy density and laser 
continuous output are the most important factors that 
affect the efficacy of Low Power Laser in patients with 
KOA. It seems that differences in these parameters are 
causing heterogeneity in the meta-analysis results. The 
wavelengths used in the entered trials was between 830 
to 904 nm and the energy density was between 0.76 to 
50 J/cm² as well as laser output varied between 4 to 800 
mW. It seems that the differences in wavelength, laser 
output and energy density in the entered trials may result 
in heterogeneity. The total numbers of treatment sessions 
in the underlying trials were between 8 to 20 sessions and 
the length of treatment times varied between 6 and 160 
minutes and this probably caused the different results of 
the LLLT efficacy. On the other hand, if the illness severity 
is mild, treatment effectiveness will be more evident. So 
LLLT do not have enough effectiveness for severe cases. It 
seems that the application of LLLT combined with other 
methods such as physical exercises leads to better clinical 
outcomes. Most attrition during follow-up periods were 
related to studies of Shen et al22 (13 cases), Hinman et al19 
(32 cases), Kheshie et al20 (7 cases) and Alfredo et al13 (6 
cases). Reduced sample size may lead to biased results in 
these trials.
The last systematic study in this area in recent years 
belongs to Huang et al.10 However, the study neither 
encompasses some related articles, nor considers 
follow-up period of outcomes in the analysis, it also 
does not analyze consequences such as pain at rest, pain 
during activities and quality of life.  The most important 
limitation of this study is, of course, high heterogeneity 
between studies that is the reason for using random 
model for meta-analysis. Moreover, another limitation of 
this study is small sample size in each paper and generally 
low sample size of outcomes which were analyzed. 
Three articles in reviewing of pain outcome, 2 articles in 
reviewing of activity outcome and 3 articles in reviewing 
of motion range reported just the mean without standard 
deviation and exact P value. We tried to make contact with 
the corresponding authors of these trials. Unfortunately, 
we did not get any response. Incomplete statistical data 
caused data exclusion from analysis and this may affect 
the results.
Conclusion
The results of our systematic review and meta-analysis 
have provided the best current evidence on LLLT in the 
treatment of KOA. Although the heterogeneity of the 
results calls for  caution in interpretation, LLLT seemed 
to be effective in reducing pain and improving function 
in patients with KOA. In spite of some positive findings, 
this meta-analysis lacked data on how LLLT effectiveness 
is affected with important factors: wavelength,  energy 
density, continuous laser output, treatment duration, 
number of treatment sessions, lost to follow-up, severity 
of KOA and site of application.
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